Despite its very recent approval, startups are already lining up to prescribe it
Various studies have found that, among patients with type 2 diabetes, a history of myocardial infarction or stroke, or arteriosclerotic cardiovascular disease, liraglutide use was associated with a lower incidence of cardiovascular disease than in the control group [16]
Perhaps the most telling statistic: patients who lost more than 20% of their total body weight experienced alopecia at a rate of 5.3%, while those who lost less than 20% reported it at just 2.5%
It is important to identify the patients who might see the most improvement
The Precision Peptide Genetic Test available through PlexusDx identifies your genetic predispositions across 14 metabolic pathways and 150+ health insights
If you keep your routines and plan ahead, you can maintain your progress